Organon Makes Deal With Huya For Access To Chinese Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
While other firms stream to China in search of drug discoveries, Huya aims to bring vetted Chinese drug candidates to the West, CEO Mireille Gingras tells “The Pink Sheet” DAILY.